Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck

Laryngoscope

Volumn 111, Issue 8, 2001, Pages 1430-1433

  Sung, Myung Whun ^a,b   Lee, Dong Wook ^a,b   Kim, Dong Young ^a,b   Lee, Sang Jun ^a   Hwang, Chan Ho ^a   Park, Seok Woo ^b   Kim, Kwang Hyun ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Congenital lymphatic malformations; Picibanil sclerotherapy

Indexed keywords

PICIBANIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGENITAL LYMPHATIC SYSTEM DISORDER; CONTROLLED STUDY; FEMALE; HEAD AND NECK MALFORMATION; HUMAN; INFANT; MALE; PAROTID GLAND; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLEROTHERAPY; TONGUE; TREATMENT OUTCOME;

EID: 0034897630     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200108000-00020     Document Type: Article

References (8)

1. Lymphatic malformations of the head neck
2. Pediatric lymphangioma of the head and neck
3. Hemangioma and vascular anomalies of the head and neck
4. OK-432 therapy in 64 patients with lymphangioma
5. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck
6. OK-432 Therapy for lymphangioma in children: Why and how does it work?
7. Treatment of lymphangiomas in children: An update of picibanil (OK-432) sclerotherapy
8. Successful treatment of a recurrent large cystic hygroma in a child with intracystic injection of OK-432